NEWS: Curebase closes $40M Series B with strategic investment by Gilead. Read about it in TechCrunch, Fierce Biotech, andEndpoints News.
Featured News
5 MINS
January 24, 2023
Curebase is a one-stop shop for running your digital therapeutics trial from start to finish
Fierce Biotech
May 5, 2022
TechCrunch
Endpoints News
Expanding decentralized clinical trials demands flexibility
PUBLISHED
Oct 5, 2022
Health app companies wrestle with how to design studies to prove treatments work
Sep 29, 2022
Curebase partners with Meru Health for 3-year mental health trial
Sep 22, 2022
The Key To Innovation In Clinical Research? Listening.
November 29, 2022
Smarter Clinical Trials with Jane Myles
Note to File Podcast - Episode 45: Jane Myles, Decentralized Clinical Trials: Evidence of Impact
April 26, 2022
Note to File Podcast - Episode 41: Jane Myles, VP Innovation at Curebase
March 29, 2022
4 MINS
December 6, 2022
Publication provides a foundational set of expectations outlining the necessary clinical evidence to enable appropriate and efficient assessment reflective of the unique nature and innovation cycles of DTx products
January 4, 2023
December 13, 2022
December 1, 2022
Interested in staying up to date with Curebase's latest developments in the decentralized clinical trial space? Get regular updates on news, webinars, blogs and more by subscribing here.
.svg)
%201.svg){kind=logo}
.jpg)
